Head-to-head · WeighScore
Direct Meds vs Novi
The verdict
Direct Meds takes it — 82.6/100 to 59.9/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Direct Meds | Novi |
|---|---|---|
| WeighScore | 82.6/100 | 59.9/100 |
| Grade | B− | C |
| Scorecard rank | #19 | #331 |
| Semaglutide | $179/mo | $174/mo (starting dose, compounded) |
| Tirzepatide | $224/mo | $283/mo (starting dose, compounded) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #19 · B−
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Graded #331 · C
Strengths
- Transparent all-in monthly pricing — medication, clinician support, and shipping bundled with no hidden fees or membership add-ons
- Both compounded semaglutide and tirzepatide available
- Unlimited clinician messaging included at no extra cost
- Free 2-day shipping on every refill
Where it loses points
- Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
- 3-month minimum commitment is non-refundable per Terms of Service unless a clinician deems treatment medically inappropriate
- State availability and pharmacy partners not publicly listed — patients learn during intake which states and pharmacies serve them
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.